The Story of Influenza Antivirals: Part 7

Enter Freddy Flu

So, to sum up, we had a BMJ-published review missing eight trials compared to its previous version. It had bland conclusions and was missing a mass of complex and unverifiable data of possible great importance as policies worldwide had been based on its findings. 

We knew the data was there, Roche had sort of promised us access under pressure from the me…